EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Managing patients in the post-HVAD era: Clinical and surgical realities of HeartMate 3 exchanges

Artur Łapaj, Katarzyna Opiłka, Maja Butrym

Polish Annals of Medicine · 09.07.2026 · 33 · 211-218

DOI: 10.31648/paom/223211 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Polish Annals of Medicine, online erschienen am 09.07.2026. Verfasst von Artur Łapaj und 2 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Durable mechanical circulatory support (MCS) is a key therapy for advanced heart failure. In 2021, the HeartWare HVAD (HVAD)—one of the primary devices used for MCS—was globally withdrawn due to high rates of pump thrombosis and neurological adverse events. This established the HeartMate 3 (HM3) as the current standard of care.

Aim

This review synthesizes the biomechanical differences between the HVAD and HM3. It also provides a clear overview of the clinical consensus and the surgical strategies needed for device exchange. Material and methods For this narrative review, a comprehensive literature search of the PubMed/MEDLINE database was conducted to find peer-reviewed articles on the biomechanics, clinical outcomes, and surgical exchange protocols for the HVAD and HM3 systems. Results and discussion The narrow-gap design of the HVAD causes higher shear stress than the fully magnetically levitated HM3. Because device exchange carries an approximate 10% 30-day mortality rate, STS-INTERMACS registry data support a conservative "for cause" exchange strategy rather than elective replacement. During emergency exchanges, surgeons face hardware incompatibility and severe mediastinal adhesions. Managing these challenges requires off-label techniques, such as removing the retained apical sewing ring or using extra-anatomic outflow graft anastomoses.

Conclusions

Although the HM3 improves survival, losing the smaller HVAD creates a treatment gap for patients with limited chest space, affecting both adult and pediatric populations. Until new compact devices are available, clinicians must focus on strict medical management of retained devices and refine high-risk surgical exchange strategies.

Zitieren

APA

Łapaj, A., Opiłka, K., & Butrym, M. (2026). Managing patients in the post-HVAD era: Clinical and surgical realities of HeartMate 3 exchanges. Polish Annals of Medicine, 33, 211-218. https://doi.org/10.31648/paom/223211

Vancouver

Łapaj A, Opiłka K, Butrym M. Managing patients in the post-HVAD era: Clinical and surgical realities of HeartMate 3 exchanges. Polish Annals of Medicine. 2026;33:211-218. doi:10.31648/paom/223211

BibTeX
@article{apaj2026,
  author = {Łapaj, Artur and Opiłka, Katarzyna and Butrym, Maja},
  title = {Managing patients in the post-HVAD era: Clinical and surgical realities of HeartMate 3 exchanges},
  journal = {Polish Annals of Medicine},
  year = {2026},
  volume = {33},
  pages = {211--218},
  doi = {10.31648/paom/223211}
}
Kostenlos starten →